Target intelligence / Profile preview

CD4-positive Helper T Cell Activation (CD4+ T cell activation)

Target
CD4+ T cell activation
Molecular classification
Cellular process, Signal transduction pathway
01

Overview

CD4-positive helper T cell activation is the process by which naive CD4+ T cells become activated upon encountering their specific antigen presented by professional antigen-presenting cells (APCs). This activation is a critical step in adaptive immunity, enabling these cells to orchestrate and regulate immune responses through cytokine secretion and interaction with other immune cell types. Activation requires antigen recognition via the T cell receptor (TCR) and co-stimulatory signals, leading to signal transduction and differentiation into various effector subtypes (Th1, Th2, Th17, Tregs). These activated cells are essential for activating B lymphocytes, supporting cytotoxic CD8+ lymphocyte responses, and recruiting innate immune effectors.

Other names
Helper T cell activationCD4+ T lymphocyte activationT helper cell activation
02

Mechanism of action

Varies depending on the specific drug; targets include signal transduction pathways, cytokine production, or co-stimulatory molecules.

03

Biological functions

Immune responseT cell proliferationCytokine productionAdaptive immunityB cell activationCD8+ T cell supportRecruitment of innate immune effectors
04

Disease associations

ImmunodeficiencyAutoimmunityInfectionCancerInflammation
05

Safety considerations

Immunosuppression leading to increased risk of infectionIncreased risk of malignancyCytokine storm (in cases of excessive activation)Autoimmunity (in cases of dysregulation)
06

Interacting drugs

Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Sirolimus)

1 more in the full profile.

07

Biomarkers

Expression levels of activation markers (e.g., CD69, CD25, HLA-DR)Cytokine profiles (e.g., IFN-gamma, IL-4, IL-17)Transcription factor activity (e.g., NFAT, NF-kB)T cell receptor signaling moleculesMHC-II expression

Beyond the preview

Go deeper on CD4-positive Helper T Cell Activation (CD4+ T cell activation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4-positive Helper T Cell Activation (CD4+ T cell activation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call